US FDA Revised Schedule for Final Phase of Investigations into Glycine Imports from China, India, Japan, and Thailand

Summary

The US FDA has announced a revised schedule for the final phase of investigations into the importation of glycine from China, India, Japan, and Thailand. The FDA will review the safety and efficacy of the imported glycine before making a final decision.